INTRODUCTION {#S1}
============

Healthy adults are very good at detecting cognitive failures, whereas a common feature of many psychiatric and neurological conditions is a diminished capacity for performance monitoring ([@R47]). Deficits in error detection have also been found to relate to clinical symptoms, including the debilitating symptoms of loss of insight ([@R30]), perseverative behaviour ([@R10]) and delusions of alien control in schizophrenia ([@R11]), and poor clinical outcomes (e.g., inability to maintain independent living ([@R42])).

Consistent with behavioural symptoms of impaired performance monitoring, past research has repeatedly identified diminished error-related anterior cingulate cortex (ACC) activity in a range of clinical conditions, including schizophrenia ([@R1]; [@R4]; [@R46]), major depression ([@R44]), and drug addiction ([@R9]; [@R22]). Performance monitoring deficits in drug abusing populations are of interest because they relate not only to features such as loss of insight, but also dysfunction in the cognitive control system ([@R39]). Cognitive control processes are fundamental to the ability to inhibit the immediate pursuit of pleasurable stimuli, and for the development of adaptive patterns of behaviour - both key factors in drug abuse ([@R21]). Previous research has not examined performance monitoring in chronic cannabis users, although it is of interest due to cannabis's links with executive dysfunction and the emergence of psychotic symptoms.

Current evidence suggests that the neural response to errors involves a network of regions ([@R39]), which consistently involves the dorsal ACC. Studies specifically examining the neural correlates of error awareness have implicated much of the same error-related cortical network ([@R19]; [@R26]; [@R34]; [@R35]), with awareness most strongly associated with activity in the insula (anterior inferior portion), right dorsolateral prefrontal and bilateral parietal regions. Each of these studies found that error-related ACC activity was present for both aware and unaware errors, but did not differentiate between them, suggesting that ACC activity may be necessary, but not sufficient, for error awareness.

Given the relationship between error-related ACC activity and error awareness in healthy adults, it remains unclear whether the poor error awareness found in psychiatric groups is related to their diminished error-related ACC activity. Similarly, cortical regions that appear critical to error awareness, such as the insula cortex, have been associated with insight problems in drug abuse ([@R36]). The aim of the present study was to examine the neural correlates of error awareness in chronic cannabis users, using a task we have previously verified as sensitive to the neural mechanisms underlying error awareness ([@R19]) and awareness impairments in drug abuse ([@R20]). Previous research with chronic cannabis users has identified diminished ACC activity during executive control tasks ([@R3]; [@R8]; [@R17]), but no study to date has examined performance monitoring.

Methods and Materials {#S2}
=====================

Subjects {#S3}
--------

Sixteen active cannabis users (1 female, mean age = 24.7, range = 18-40) and 16 matched control participants (1 female, mean age 25.3, range: 20-36) were recruited from University campuses within Dublin City, Ireland, via leaflet advertising. After complete description of the study to the subjects, written informed consent was obtained. Groups were also matched for educational attainment (Control: 17.8 years, Cannabis: 16.2, *F*(1,31) = 2.71, *p* = .11) and National Adult Reading Test (NART) estimated IQ (Control: 124.0, Cannabis: 123.3, *F*(1,31) = .26, p = .61). A semi-structured interview was used to screen participants for past or present history of psychiatric or neurological illness. All participants completed inventories of drug use (questionnaire taken from the Addiction Severity index Lite-CF) to screen for past or concurrent abuse of other substances. Prospective participants from either sample were additionally considered ineligible if they reported concurrent or past dependence on other drugs (including nicotine and alcohol). Information concerning alcohol and cannabis use in each participant was indexed in number of years (life-time) and occasions of recent use (last 30 days) and is presented in [Table 1](#T1){ref-type="table"}. The groups did not differ on any measure of drug use other than those relating to cannabis.

Participants in the cannabis group were required to have regularly consumed cannabis (5-7 days/week) for the previous 2 years and to have smoked a minimum of 500 joints in their life-time in order to be eligible for the study. All cannabis users provided a positive urine sample for Δ^9^-tetrahydrocannabinol (Δ^9^THC) prior to scanning, with additional screening for other confounding drug use (Cozart® RapiScan, UK) taking place. Control participants were also tested for Δ^9^THC and the above adulterants. Participants providing positive tests for drugs other than cannabis (cannabis group only) or alcohol were excluded, and all participants provided a .00 breath blood alcohol concentration reading prior to beginning testing.

Behavioural Tasks {#S4}
-----------------

### Error Awareness Task {#S5}

To examine conscious recognition of errors we administered the Error Awareness Task (EAT) (see [Figure 1](#F1){ref-type="fig"}) ([@R19]), a motor Go/No-go response inhibition task in which subjects make errors of commission of which they are aware (Aware errors), or unaware (Unaware errors). The EAT presents a serial stream of single colour words in congruent fonts, with the word presented for 900ms followed by a 600ms inter-stimulus interval. Participants were trained to respond to each of the words with a single 'Go trial' button press, and withhold this response when either of two different circumstances arose. The first was if the same word was presented on two consecutive trials (Repeat No-go), and the second was if the word and font of the word did not match (Stroop No-go). By having competing types of response inhibition rules we aimed to vary the strength of stimulus-response relationships, whereby representations of rules competitively suppress one another such that the more prepotent rule would suppress the weaker rule and so produce a significant number of errors, a small proportion of which may go unnoticed due to focusing primarily on the prepotent rule. In particular, we aimed to capitalise on the overlearned human behaviour of reading the word, rather than the colour of the letters (the Stroop effect), and so predispose participants to monitor for the Repeat, rather than the Stroop, No-go's. To indicate 'error awareness' participants were trained to press the go-trial button twice on the trial following any commission errors.

Before entering the MRI scanner, participants practiced two novel blocks of the task to ensure they understood the task instructions. Five blocks of 225 trials (200 Go trials, 25 No-go trials) for a total of 1125 trials were administered during MRI data collection, with each block separated by a short break. An equivalent number of Stroop and Repeat No-go trials were administered across the 5 blocks for a total of 62 repeat and 63 stroop no-go trials. All aspects of stimulus delivery and response recording were controlled by E-Prime software (version 1.1 Psychology Software Tools, Pittsburgh, PA), running on a laptop PC (Celeron 2Ghz, 128mb Nvidia Video Card), which was interfaced with the MR scanner during acquisition of fMRI data. Stimuli were back projected onto a screen at the head of the scanner bed, with a head-coil mounted mirror enabling participants to view stimuli. Participants responded to each stimulus using their right hand, entering their response on an MR-compatible response box (Fibre-Optic response pads, Current Designs, Philadelphia, PA, USA).

#### Image Acquisition {#S6}

Functional MR images were acquired at Trinity College Institute for Neuroscience, Dublin City, Ireland, using a Philips Intera Achieva 3.0 Tesla MR system (Best, The Netherlands) with a gradient-echo echo-planar imaging (EPI) sequence. The scanner was equipped with a radiofrequency birdcage head coil for signal transmission and reception. Lateral head stabilizers were used to minimize head movement. EPI images were acquired using a gradient-echo pulse sequence and sequential slice acquisition (T~R~ = 2000ms, T~E~ = 35ms, flip angle = 90°, 32 non-contiguous slices of 3.5 mm thickness, 10% gap, in-plane resolution of 3.5 × 3.5 pixels in a FOV of 224mm). Each functional run began with four volume acquisitions that were later discarded, to allow for steady-state tissue magnetization. Activation data were registered to high-resolution T1-weighted isotropic (0.9mm^3^) structural MPRAGE images to localise the pattern of physiological changes associated with the task.

#### Data Analysis {#S7}

Behavioural data from each participant were used to categorise the No-go trial events into successful responses (stops), aware errors, and unaware errors. All analyses were conducted using AFNI software (<http://afni.nimh.nih.gov/afni/>)([@R5]). Following image reconstruction, the time-series data were motion-corrected using 3D volume registration (least-squares alignment of three translational and three rotational parameters). Activation outside the brain was removed using edge detection techniques.

Separate haemodynamic response functions (HRFs) at 2-second temporal resolution were calculated using deconvolution techniques for aware errors, unaware errors and stop events. A non-linear regression program determined the best-fitting gamma-variate function for these HRFs as previously described ([@R32]). The area under the curve of the gamma-variate function was expressed as a percentage of the area under the baseline. The baseline in this design is an implicit one and is indicative of task-related go-trial processing that remains after the variance related to the other types of events have been removed.

The percentage area (event-related activation) map voxels were re-sampled at 1mm^3^ resolution, then spatially normalised to standard MNI space (MNI 152 template), and spatially blurred with a 3mm isotropic rms Gaussian kernel. Group activation maps for event-type (aware errors, unaware errors, stops) were determined with one-sample t-tests against the null hypothesis of zero event-related activation changes (i.e., no change relative to baseline). Significant voxels passed a voxelwise statistical threshold (*t* = 4.31, *p* ≤ .001) and were required to be part of a larger 142μl cluster of contiguous significant voxels. By using a combination of probability thresholding and cluster thresholding, the aim is to maximise the power of the statistical test while holding the likelihood of false-positives to a minimum. To determine the cluster threshold we use a program called Alphasim (<http://afni.nimh.nih.gov/pub/dist/doc/program_help/AlphaSim.html>).We provide the program with the number of voxels in the group map, the spatial correlation of voxels (must be contiguous on three sides), and the voxelwise threshold (in this study, p = .001). The program then runs a series of Monte Carlo simulations (1000 iterations for our study) to determine the frequency of clusters of varying sizes produced by chance. From this frequency distribution, we then select the cluster size (142μl given our parameters) that occurs less than 1% of the time by chance, to give a threshold of *p* = .01 (corrected).

The comparison of interest was between aware and unaware errors. The activation clusters from whole-brain analyses of both aware and unaware errors were used to create an OR map for the purposes of an ROI analysis. An OR map includes the voxels of activation indicated as significant from either of the constituent maps. The mean activation for clusters in the combined map was then calculated for the purposes of an ROI analysis, deriving mean activation levels for aware and unaware errors that were compared using repeated measures t-tests, corrected via a modified Bonferroni procedure for multiple comparisons ([@R24]).

The approach of combining aware and unaware error maps was taken due to the relatively small number of unaware error events (on average, 32 aware and 13 unaware errors per subject). Previous use of this approach with results from this task ([@R19]) have demonstrated that the analysis is not biased toward activity from aware errors. While the number of events has been shown to influence the spatial extent of activation ([@R41]), it does not affect the level of activation in a functionally defined ROI-type analysis ([@R32]) as used here.

To confirm that activation seen during aware errors did not represent the changed response demands (i.e., altering the response to indicate awareness), we have previously administered an Oddball condition during MRI data collection to identify activations associated with the changed response demands of the aware errors. This condition replicated the stimuli and timing from the EAT task. Oddball events therefore represented similar response and decision requirements to aware errors, without the subject making an error. The Oddball condition indicated significant activation (greater than zero) in only one of the Aware ROIs (Left Middle Temporal Gyrus, BA 21), confirming that the differences between Aware and Unaware errors did not result from this requirement.

Results {#S8}
=======

Behavioural Results {#S9}
-------------------

Performance indices for both control and cannabis participants are presented in [Table 2](#T2){ref-type="table"}. Control participants' inhibitory control, as measured by No-go accuracy, was not significantly different to cannabis participants, *F*(1,31)= 0.45, *p*=.83. Control participants were aware of over 91% of their No-go errors, a significantly higher proportion in comparison to 77% for cannabis users, *F*(1,31)= 5.27, *p*=.03. Control participants' Go trial response speed was not significantly different to the cannabis group. Go RTs were significantly slower than aware error RT's for both groups, but no difference was found for unaware errors.

In summary, the cannabis group displayed equivalent inhibitory control performance, but significantly poorer error awareness.

### Relationship between cannabis-use behaviour and cognitive task performance {#S10}

No-go accuracy and error awareness indices from the EAT task were examined for relationship to self-report measures of cannabis use in the cannabis group. No-go accuracy did not significantly correlate with any of the self-report measures. However, approaching significance was the association with the reported age of onset for cannabis use (*r*= .42, *p*= .10), whereby earlier onset of cannabis use was associated with poorer inhibitory control. Significant relationships were identified between indices derived from the Marijuana Craving questionnaire and individual differences in error awareness, specifically Emotionality (*r*= .54, *p*= .03) and Purposefulness (*r*= .51, p= .04). These constructs characterized the questions that related to the use of cannabis in anticipation of relief from withdrawal or negative mood (Emotionality), and the intention and planning to use cannabis due to its previous rewarding/positive mood inducing qualities (Purposefulness) ([@R18]). The positive relationship observed indicates that heightened states of 'emotional craving' were associated with poorer error awareness.

Imaging Data {#S11}
------------

### Errors {#S12}

An analysis combining all participants showed that No-go errors were associated with significant activity in the posterior medial frontal cortex (see [Fig. 2](#F2){ref-type="fig"}). The centre-of-mass for this cluster of activity was located in the right dorsal anterior cingulate cortex (MNI co-ordinates: x= 2; y= 21; z= 36), which falls within the rostral cingulate zone highlighted by Ridderinkhof and colleagues' review of performance monitoring ([@R39]). Within this functionally defined ROI, aware errors were associated with significantly higher levels of BOLD activity compared with unaware errors. Activity in several other regions also differentiated aware from unaware errors (see [Table 3](#T3){ref-type="table"} **and** [Figure 2](#F2){ref-type="fig"}), including right insula, bilateral inferior parietal, right middle frontal (Brodmann's Area 6), right putamen, right middle occipital, right cerebellum and left middle frontal cortices (BA 10). No region showed significantly greater activity for unaware errors when compared to aware errors. When averaging over aware and unaware errors, no main effect of group was found in any of these error-related regions.

Using the functionally defined clusters from the error-related activity map, we conducted a region of interest (ROI) analysis comparing aware and unaware error-related activity separately for each group. Error awareness for control participants was associated with significant differences in four of the awareness ROIs (see [Figure 2](#F2){ref-type="fig"}); greater activity for aware errors was seen in the right insula and left inferior parietal regions when compared to unaware errors, whereas greater deactivation for unaware errors was seen for the right middle occipital and right cerebellar regions. Similar to controls, the cannabis group showed greater activity for aware errors (when compared to unaware errors) in the right insula and left IPL. In contrast to controls, the users also showed aware-unaware differences in the right ACC, right middle frontal and left middle frontal regions when compared to unaware errors, whereas significantly more deactivation during unaware errors was seen for the right putamen and right middle occipital regions.

Separate between-group comparisons for aware and unaware errors did not reveal significant group differences in the regions previously differentiating aware from unaware errors. However, group differences were observed during aware errors in a number of regions that the previous analysis showed did not differentiate between aware and unaware errors: greater activity was seen for cannabis users in the left putamen and bilaterally in the precuneus, as well as less deactivation in left caudate and left hippocampal regions when compared to control participants.

The relationship between error-related activity and individual differences in error awareness was further examined using Pearson correlation coefficients. BOLD activity difference scores were derived for each participant by subtracting unaware from aware error-related activity. Due to the group differences in behavioural performance the correlation analysis was performed separately in each group. Individual differences in error awareness levels in the cannabis group significantly correlated with error-related activity difference scores in the right ACC (*r* = .50, *p* = .05), and approached significance in the right insula (*r* = .45, *p* = .08) region. Including inhibition accuracy as a covariate did not alter the significance or strength of relationship between individual differences in error awareness and error-related BOLD activity in the ACC (r = .50, P \< .05) or right insula (r = .45, p = .09) for cannabis users. The null effect of this covariate is consistent with the absence of correlation between the behavioural measures of error awareness and inhibition accuracy (r = .04). Individual differences in error awareness rates for the control group did not significantly correlate with activity in any of the error awareness regions. The absence of significant relationships may have been influenced by the limited variability in rates of error awareness for the control group (range = 69% to 98%).

### Relationship between cannabis-use behaviour and error-related BOLD activity {#S13}

The relationship between error-related activity and individual differences in self-reported measures of cannabis use were examined using Pearson correlation coefficients. BOLD activity scores for each error type were correlated with the indices of use. Aware error activity in the right ACC correlated negatively with reported use in the past month (*r*= -.51, *p*= .04) and right insula activity correlated negatively with use in the past week (*r* = -.53, *p* = .03). Unaware error activity in the right insula was negatively correlated with reported use in the past year (*r* = -.56, *p* = .03). The negative correlations indicate a relationship between higher levels of reported cannabis use and lower BOLD activity for the respective regions.

Self-report measures of craving and withdrawal did not correlate with BOLD activity in any of the error-related ROIs.

#### Stops {#S14}

Event-related BOLD activity during Stops indicated 14 clusters of significant activity, including the right prefrontal, parietal and anterior cingulate regions previously seen with other versions of the Go/No-go task (see [Table 4](#T4){ref-type="table"}). A group comparison revealed significant differences in three regions, the right IPL, right putamen and right middle cingulate gyrus. The latter cluster (MNI co-ordinates: x = 3; y = -14; z = 49) is dorsal to the anterior cingulate cortex, and falls within the pre-supplementary motor area previously identified in response inhibition performance ([@R13]; [@R14]; [@R31]; [@R48]). In all three regions, the pattern of BOLD activity indicated significantly higher levels for the cannabis group when compared to the control group.

Discussion {#S15}
==========

Cannabis using participants displayed significantly poorer awareness of errors than a matched control sample. The awareness deficit occurred in the absence of a primary task performance deficit: control and cannabis groups made equivalent numbers of inhibitory control errors from which awareness was assessed. The failure to recognize an error was associated with hypoactive BOLD responses in the cannabis group, in cortical regions including the ACC, right insula, bilateral inferior parietal and middle frontal regions (when compared to aware error activity). In contrast to control participants and previous studies examining error awareness ([@R19]; [@R26]; [@R34]), cannabis users did not show significant ACC activity during unaware errors (see [Figure 2](#F2){ref-type="fig"}). One interpretation of these results is that the failure of the ACC (and other regions such as the bilateral middle frontal gyri) to activate for all errors underlies the poorer awareness of errors by cannabis users.

The hypoactive error-related ACC response observed in the cannabis group is consistent with similar diminished responses in schizophrenia ([@R1]; [@R2]; [@R4]; [@R25]; [@R27]; [@R46]), major depression ([@R44]), ADHD ([@R28]; [@R40]) and various drug dependent samples (e.g., cocaine ([@R22]), methamphetamine ([@R29]), heroin ([@R9]), alcohol ([@R38])). The current study is the first to demonstrate that such ACC hypoactivity may be linked to failures of error awareness. Indeed, the present data suggest that error-related ACC hypoactivity is specific to those errors of which the participant was not aware. Previous studies demonstrating error-related ACC hypoactivity had not examined error awareness, or they had provided event-related performance feedback to negate the requirement for error detection. Given the current finding, we speculate that the diminished error-related ACC response observed in psychiatric populations may also be associated with, but not exclusively explained by, deficits in error awareness. For example, we have shown in separate studies of cocaine users that they demonstrate deficient error awareness and hypoactive error-related ACC ([@R20]; [@R22]), and similar studies demonstrate the same pattern in schizophrenia ([@R4]).

BOLD activity in two other cortical regions also appeared to differentiate aware from unaware errors for cannabis users, but not control participants. Cannabis users showed less deactivation in the left middle frontal gyrus (BA 10) and right putamen during unaware errors when compared to their aware errors, whereas control participants showed no difference in these regions. The opposite pattern was observed in the right cerebellum, with control participants demonstrating significantly less activity (deactivation) during unaware errors when compared to aware, whereas the cannabis group showed no difference. Common to both groups was the differentiation of aware from unaware errors by greater activity in the right insula, bilateral IPL and right middle frontal cortices, as well as significantly less deactivation in the right middle occipital cortex. In support of this group effect, the correlational analyses also found that cannabis group participants with high levels of ACC activity during aware errors (relative to unaware errors) had higher error awareness rates. A similar, but non-significant (*r* = .45, *p* = .08), relationship was found between activity in the right insula and error awareness.

Error-related insula activity has previously been associated with error awareness in healthy controls ([@R19]; [@R26]). Klein and colleagues highlighted that such activity was consistent with the hypothesis that insula activity reflects interoceptive awareness ([@R7]). Recent work has also suggested that the insula and interoceptive awareness are critical to drug craving and addiction ([@R16]; [@R33]; [@R36]), whereby the insula monitors interoceptive 'urges' for rewarding stimuli such as a drug of addiction. These hypotheses suggest insula dysfunction may contribute to impaired interoceptive awareness and heightened experience of drug-related urges, potentially at the expense of other interoceptive signals - for example decision-making ([@R6]; [@R36]). The relative insensitivity of our cannabis group to detecting errors, which was associated with the absence of right insula activity during unaware errors, would appear consistent with this hypothesis. Furthermore, lower levels of insula activity were correlated with higher levels of recent cannabis use, and higher levels of cannabis craving were associated with poorer error awareness rates. Our data did not reveal a relationship between self-reported craving and insula activity, however further research might examine if manipulating drug-craving (e.g., using drug-related cues) influences insula activity and error awareness during cognitive task performance.

It is also of interest how the diminished capacity for monitoring performance observed here, might contribute to the cognitive control dysfunction that is considered critical to the continuation of drug abuse ([@R15]). Error-related ACC activity is known to prompt subsequent adaptive increases in both cognitive control performance and BOLD activity in regions such as the dorsolateral prefrontal cortex ([@R14]), and the diminished responses seen in psychiatric populations have been demonstrated to compromise these adaptive changes ([@R25]). The lack of contingency between errors and subsequent task performance in the current study prevents us from examining if the diminished error awareness contributes to subsequent cognitive control dysfunction - for example the failure to learn from errors that underlies perseverative behaviour.

The equivalent cognitive control performance of the cannabis group and their significantly greater activity in right IPL, putamen and middle cingulate (Pre-SMA) regions during correct inhibition trials (when compared to the control group) is consistent with previous studies in recently abstinent adolescent ([@R45]) and adult ([@R17]) cannabis users. All three cortical regions have consistently been associated with successful response inhibition performance in healthy controls ([@R12]; [@R23]). Studies with cannabis users have demonstrated a consistent pattern of increased activity in prefrontal and parietal regions, with the Tapert et al. study (which administered a Go/No-go task) demonstrating increased activity in the pre-SMA and right IPL regions that was also observed here. These results have been interpreted as support for a compensatory mechanism in cannabis users, where maintaining equivalent cognitive control performance requires recruitment of additional cortical regions (than those associated with cognitive control in matched controls), or additional activity from regions common to both groups.

The emergence of a behavioural error awareness deficit in the cannabis group and the associated BOLD activity differences should also be considered in the context of our sample's demographic and drug use profile. Our sample were young, high functioning adults who had been using cannabis for the past 8 years from an average onset age of 16. Based on previous literature ([@R37]; [@R43]), the present sample reported mild to moderate levels of recent cannabis use that has typically not been associated with deficits on clinical neuropsychological measures. Consistent with this characterisation, the present cannabis group's inhibitory control performance on the Go/No-go task showed no sign of impairment. The absence of significant group differences in the magnitude of error-related BOLD activity, despite the presence of group differences in the regions that were associated with error awareness, might also be consistent with the relatively limited duration and frequency of use in our sample. For example, the greater frequency of recent use (past week, month, year) was significantly correlated with lower levels of error-related ACC activity. Given the consistency with which diminished error-related activity has been demonstrated in long-term chronic users of other drugs, the absence of this effect requires follow-up with longer-term cannabis users.

The presence of a performance monitoring deficit and its accompanying BOLD changes in our sample suggest that it may be present in the early stages of drug abuse or may indeed precede use and constitute a risk factor for prolonged cannabis use. This prompts the question of whether such a deficit might contribute to the maintenance of drug use, or represent a deficit that accompanies chronic drug use because of systematic changes in the executive control system that underlies performance monitoring.

This research was supported by USPHS grant from the National Institute on Drug Abuse: DA01865-01, Australian Research Council Grant (R.H.) DP0556602 and Australian National Health and Medical Research Council Career Development Award 519730 (R.H.). The assistance of Gloria Roberts, Gina Joue, Jennifer Jones and Ella McCabe are gratefully acknowledged.

Disclosures

Drs Hester, Nestor and Garavan reported no biomedical financial interests or potential conflicts of interest.

![The Error Awareness Task\
The EAT presents a serial stream of single colour words in congruent fonts, with the word presented for 900ms followed by a 600ms inter-stimulus interval. Participants were trained to respond to each of the words with a single 'Go trial' button press, and withhold this response when either of two different circumstances arose. The first was if the same word was presented on two consecutive trials (Repeat No-go), and the second was if the word and font of the word did not match (Stroop No-go). To indicate 'error awareness' participants were trained to press the go-trial button twice on the trial following any commission errors.](nihms-118824-f0001){#F1}

![Regions of brain activity differentiating Aware from Unaware Errors\
Bar graphs represent mean BOLD % signal change (relative to baseline) for each group during Aware and Unaware errors. Error bars represent the standard error of the mean. The MNI co-ordinates for each region are listed in the title and the brain slices shown represent the view at the relevant x, y or z-coordinate (e.g., coronal slices relate to the y-coordinate). Significant within-group comparisons for aware and unaware errors are indicated by the bar and asterisk notations.](nihms-118824-f0002){#F2}

###### 

Mean and SEM for control and cannabis groups on demographic and drug use history

                                                  Control       Cannabis
  ----------------------------------------------- ------------- ------------------
  Age                                             25.2 ± 1.3    24.6 ± 1.5
  Years of Education                              17.7 ± 0.7    16.2 ± 0.7
  Verbal Intelligence Score (NART)                124.0 ± 0.8   123.3 ± 0.8
  Beck Depression Inventory II Score              4.0 ± 0.7     5.5 ± 1.1
  Females/Males                                   1/15          1/15
  Years of Alcohol Use                            8.7 ± 1.4     8.9 ± 1.4
  Alcohol Use in Last Month (no. days)            6.2 ± 1.4     9.3 ± 1.8
  Alcohol Use Age Onset (Years)                   16.2 ± 0.6    15.8 ± 0.5
  Cannabis Use (Years)                            0.0 ± 0.0     8.2 ± 1.3
  Life-time Joints (number)                       3.0 ± 0.6     11628.8 ± 5993.4
  Days of Use in Last Month (number)              0.0 ± 0.0     19.2 ± 2.6
  Joints in Last Month (number)                   0.0 ± 0.0     76.3 ± 17.7
  Cannabis Use Age Onset (years)                  17.0 ± 0.3    16.4 ± 0.7
  Cannabis Abstinence (hours)                                   38.0 ± 47.7
  Cannabis Withdrawal Score (out of 32)                         9.3 ± 2.2
  Cannabis Craving Scores (each item out of 21)                 
                  *Compulsivity*                                6.0 ± 1.0
                  *Emotionality*                                8.4 ± 1.1
                  *Expectancy*                                  11.3 ± 1.3
                  *Purposefulness*                              10.1 ± 1.3

###### 

Mean accuracy, reaction time and standard deviation scores for cannabis (*n* = 16) and control (*n* = 16) groups on the Error Awareness task

  Category                              Cannabis   Controls   p               
  ------------------------------------- ---------- ---------- ------- ------- ----------------------------------
  No-go Accuracy (% correct)            53.2       22.4       51.6    19.2    
    Repeat No-go accuracy               63.8       21.1       61.3    18.1    
    Colour No-go accuracy               42.9       26.5       42.2    21.4    
  Error Awareness (% of aware errors)   77.5       24.4       91.9    6.6     [\*](#TFN1){ref-type="table-fn"}
    Repeat Error Awareness              75.2       28.1       90.0    12.2    [\*](#TFN1){ref-type="table-fn"}
    Colour Error Awareness              79.5       23.1       93.7    5.6     [\*](#TFN1){ref-type="table-fn"}
  Go RT (ms)                            515.4      98.1       531.4   81.8    
  Error RT (ms)                                                               
   Aware Error RT (ms)                  437.7      136.4      443.8   123.6   
   Unaware Error RT (ms)                513.9      169.1      521.2   160.9   

Significant difference between cannabis and control groups (*p* \< .05)

###### 

Regions of error-related BOLD activity (combined across groups) differentiating aware from unaware errors

  Brain region             Volume (μl)   MNI coordinates         
  ------------------------ ------------- ----------------- ----- -----
  R anterior cingulate     13377         2                 21    36
  R insula                 7663          41                15    -1
  L inferior parietal      7406          -41               -25   54
  R inferior parietal      5859          47                -34   48
  R middle frontal         277           28                -8    57
  R putamen                206           28                -10   5
  R middle occipital       187           29                -92   14
  R cerebellum (declive)   177           13                -80   -21
  L middle frontal         147           -29               44    24

###### 

Regions of Stop-related BOLD activity

  Brain region                 Volume (μl)   MNI coordinates         
  ---------------------------- ------------- ----------------- ----- ----
  R insula/inferior frontal    5505          41                15    -1
  R inferior parietal          3278          49                -41   42
  L Insula/inferior frontal    822           -35               15    -6
  R middle cingulate           591           2                 -18   33
  R anterior cingulate         589           5                 36    22
  R middle temporal            379           58                -28   -1
  L inferior parietal          299           -39               -51   56
  R putamen                    265           19                6     -4
  L insula                     250           -29               20    5
  R thalamus (red nucleus)     234           6                 -19   -2
  R middle cingulate/SMA       168           3                 -14   49
  R middle cingulate           158           1                 -27   28
  R middle frontal (BA 10)     153           39                49    18
  R middle frontal (BA 9/10)   146           39                40    30
